Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3956-80-7

Post Buying Request

3956-80-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3956-80-7 Usage

Type of compound

Organic fatty acid

Structure

Contains a formyl group (-CHO) attached to the eleventh carbon atom of the undecanoic acid chain

Functional groups

Carboxylic acid (-COOH) and aldehyde (-CHO) groups

Cosmetics and personal care products

Due to its moisturizing and emollient properties

Pharmaceutical industry

Potential use in the development of anti-inflammatory and anti-cancer drugs

Importance

Serves as an intermediate in the synthesis of biologically active compounds

Solubility

Generally soluble in organic solvents like ethanol, methanol, and acetone

Stability

Stable under normal temperature and pressure conditions

Reactivity

Can undergo reactions typical of carboxylic acids and aldehydes, such as esterification, reduction, and oxidation

Purity

Often synthesized and used in a pure form for specific applications

Safety

Should be handled with care due to potential irritant properties and possible adverse effects if ingested or inhaled

Storage

Should be stored in a cool, dry place, away from heat and light, and in a sealed container to maintain stability and purity

Environmental impact

As with most chemicals, proper disposal and handling are necessary to minimize environmental impact

Regulatory status

May be subject to specific regulations and guidelines depending on the intended application and region.

Check Digit Verification of cas no

The CAS Registry Mumber 3956-80-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,9,5 and 6 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 3956-80:
(6*3)+(5*9)+(4*5)+(3*6)+(2*8)+(1*0)=117
117 % 10 = 7
So 3956-80-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H22O3/c13-11-9-7-5-3-1-2-4-6-8-10-12(14)15/h11H,1-10H2,(H,14,15)

3956-80-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 12-oxododecanoic acid

1.2 Other means of identification

Product number -
Other names 12.oxododecanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3956-80-7 SDS

3956-80-7Relevant articles and documents

Design and characterization of the first selective and potent mechanism-based inhibitor of cytochrome p450 4z1

Kowalski, John P.,Mcdonald, Matthew G.,Pelletier, Robert D.,Hanenberg, Helmut,Wiek, Constanze,Rettie, Allan E.

, p. 4824 - 4836 (2020)

Mammary-tissue-restricted cytochrome P450 4Z1 (CYP4Z1) has garnered interest for its potential role in breast cancer progression. CYP4Z1-dependent metabolism of arachidonic acid preferentially generates 14,15-epoxyeicosatrienoic acid (14,15-EET), a metabolite known to influence cellular proliferation, migration, and angiogenesis. In this study, we developed time-dependent inhibitors of CYP4Z1 designed as fatty acid mimetics linked to the bioactivatable pharmacophore, 1-aminobenzotriazole (ABT). The most potent analogue, 8-[(1H-benzotriazol-1-yl)amino]octanoic acid (7), showed a 60-fold lower shifted-half-maximal inhibitory concentration (IC50) for CYP4Z1 compared to ABT, efficient mechanism-based inactivation of the enzyme evidenced by a KI = 2.2 μM and a kinact = 0.15 min-1, and a partition ratio of 14. Furthermore, 7 exhibited low off-target inhibition of other CYP isozymes. Finally, low micromolar concentrations of 7 inhibited 14,15-EET production in T47D breast cancer cells transfected with CYP4Z1. This first-generation, selective mechanism-based inhibitor (MBI) will be a useful molecular tool to probe the biochemical role of CYP4Z1 and its association with breast cancer.

Regioselective Hydroformylation of Internal and Terminal Alkenes via Remote Supramolecular Control

Linnebank, Pim R.,Ferreira, Stephan Falc?o,Kluwer, Alexander M.,Reek, Joost N. H.

, p. 8214 - 8219 (2020/06/21)

Regioselective catalytic transformations using supramolecular directing groups are increasingly popular as it allows for control over challenging reactions that may otherwise be impossible. In most examples the reactive group and the directing group are close to each other and/or the linker between the directing group is very rigid. Achieving control over the regioselectivity using a remote directing group with a flexible linker is significantly more challenging due to the large conformational freedom of such substrates. Herein, we report the redesign of a supramolecular Rh–bisphosphite hydroformylation catalyst containing a neutral carboxylate receptor (DIM pocket) with a larger distance between the phosphite metal binding moieties and the DIM pocket. For the first time regioselective conversion of internal and terminal alkenes containing a remote carboxylate directing group is demonstrated. For carboxylate substrates that possess an internal double bond at the Δ-9 position regioselectivity is observed. As such, the catalyst was used to hydroformylate natural monounsaturated fatty acids (MUFAs) in a regioselective fashion, forming of an excess of the 10-formyl product (10-formyl/9-formyl product ratio of 2.51), which is the first report of a regioselective hydroformylation reaction of such substrates.

Synthetic method of terminal carboxylic acid

-

Paragraph 0071-0074, (2019/11/21)

The invention discloses a synthetic method of a terminal carboxylic acid. The synthetic method is characterized by comprising the steps of adding an olefin represented by a formula (3) shown in the description, formic acid, acetic anhydride, Pd(OAc)2 and a monophosphorus ligand TFPP into an organic solvent in a proportion, carrying out hydrogen carbonylation reaction on the olefin represented by the formula (3) shown in the description, formic acid and acetic anhydride at 80-90 DEG C for 48h-72h under the catalysis of the metal palladium salt Pd(OAc)2 and the monophosphorus ligand TFPP so as to obtain the terminal carboxylic acid represented by a formula shown in the description, and separating a target product, namely the terminal carboxylic acid after the reaction is finished, wherein olefin represented by the formula (3) is selected from cycloolefins, or linear olefins of which the R1 is electron donating groups. By virtue of the method disclosed by the invention, corresponding terminal carboxylic acid and a derivative thereof can be prepared through the reaction under mild conditions of low temperature and no high pressure; and the steps of the synthetic method are simple and convenient, the operation is convenient, the yield is high, the energy source can be greatly saved, and the synthetic efficiency can be greatly improved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3956-80-7